Insider Transactions in Q1 2021 at Eiger Bio Pharmaceuticals, Inc. (EIGR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Evan Loh |
SELL
Open market or private sale
|
Direct |
2,000
-20.0%
|
$20,000
$10.14 P/Share
|
|
Mar 12
2021
|
David Apelian CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Mar 12
2021
|
David A Cory President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+28.51%
|
-
|
|
Mar 12
2021
|
Thomas John Dietz |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+12.5%
|
-
|
|
Mar 12
2021
|
Jeffrey S Glenn |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+6.15%
|
-
|
|
Mar 12
2021
|
Evan Loh |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Mar 12
2021
|
Eldon C. Mayer Iii Ex VP & Chief Commerc. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,875
+19.94%
|
-
|
|
Mar 12
2021
|
Christine Murray |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Mar 12
2021
|
Stephana Eilene Patton Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,875
+39.82%
|
-
|
|
Mar 12
2021
|
Sriram Ryali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+47.24%
|
-
|
|
Mar 12
2021
|
Amit Sachdev |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Mar 12
2021
|
James P Shaffer Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,875
+28.84%
|
-
|
|
Jan 08
2021
|
Eldon C. Mayer Iii Ex VP & Chief Commerc. Officer |
SELL
Open market or private sale
|
Direct |
1,690
-4.51%
|
$18,590
$11.68 P/Share
|